Horizon Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch HZNP and buy or sell other stocks, ETFs, and their options commission-free!About HZNP
Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments.
CEOTimothy P. Walbert
CEOTimothy P. Walbert
Employees—
Employees—
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2008
Founded2008
Employees—
Employees—
HZNP Key Statistics
Market cap26.63B
Market cap26.63B
Price-Earnings ratio62.16
Price-Earnings ratio62.16
Dividend yield—
Dividend yield—
Average volume4.15M
Average volume4.15M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$116.38
52 Week high$116.38
52 Week low$61.93
52 Week low$61.93
Stock Snapshot
The current Horizon Therapeutics(HZNP) stock price is $116.30, with a market capitalization of 26.63B. The stock trades at a price-to-earnings (P/E) ratio of 62.16.
During the trading day, Horizon Therapeutics(HZNP) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Horizon Therapeutics(HZNP) stock has reached 0, versus its average volume of 4.15M.
The stock's 52-week range extends from a low of $61.93 to a high of $116.38.
The stock's 52-week range extends from a low of $61.93 to a high of $116.38.
People also own
Based on the portfolios of people who own HZNP. This list is generated using Robinhood data, and it’s not a recommendation.